{"nctId":"NCT00595309","briefTitle":"Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51","startDateStruct":{"date":"2007-12"},"conditions":["Japanese Encephalitis"],"count":198,"armGroups":[{"label":"A","type":"ACTIVE_COMPARATOR","interventionNames":["Biological: IC51"]}],"interventions":[{"name":"IC51","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Main Inclusion Criteria:\n\n* Healthy adults who completed the primary immunization in study IC51 309\n* Male and female healthy subjects aged at least 18 years with written informed consent and either no childbearing potential or negative pregnancy test\n\nMain Exclusion Criteria:\n\nâ€¢ History of immunodeficiency or immunosuppressive therapy, known Human Immunodeficiency Virus (HIV), or drug addiction including alcohol dependence","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Seroconversion Rate","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"98.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Safety and Adverse Events","description":null,"classes":[]},{"type":"SECONDARY","title":"Seroconversion","description":null,"classes":[]},{"type":"SECONDARY","title":"Geometric Mean Titer","description":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":8,"n":198},"commonTop":["Nasopharyngitis","Headache","Influenza Like Illnes","Fatigue","Myalgia"]}}}